Researchers develop new strategy for broad spectrum anti-viral drugs

Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news146667439.html">Researchers develop new strategy for broad spectrum anti-viral drugs</a></p> <p>Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents.</p>